Blackstone's Bluestar goes out with HK market slide
Bluestar Adisseo Nutrition Group, the Hong Kong-registered animal feed producer owned by the Blackstone Group and China National BlueStar (Group) Co., a wholly-owned subsidiary of China National Chemical Corporation (ChemChina), has cancelled plans to raise HK$12 billion ($1.56 billion) in an IPO.
According to the company statements, Bluestar Adisseo originally planned to offer just over 2.3 billion shares, in a pricing range between HK$3.5 ($0.45) and HK$5.25 ($0.68). The public offering was supposed to float earlier last week, however the plan was scrapped at the last minutes due to market volatility. Accordingly, an underwriting agreement relating to an international placing will not be entered into, noted a statement.
Henry Ong, Partner at Weil, Gotshal & Manges LLP shared his opinion on the current trend of withdrawing or postponing planned IPOs in Hong Kong. "Aside from the recent market jitters we see, the range of factors includes: worries about China's inflation [and the] property market, the cooling measures recently implemented [in the PRC] and that are likely to come, through to parts of Europe being admitted – or which may be admitted – to the intensive care unit."
The blue-chip Hang Seng Index was down 2.8% in the past week and has slid 7.8% from its high point on November 8th.
Ong said, "The market here has had a strong run, and there has been some correction, but it's not as if the stock market has fallen apart. The underlying US (and therefore global) economic uncertainties, the Eurozone's problems, combined with more recent concerns about China's inflation and cooling measures, were enough to reduce some of the froth."
Bluestar Adisseo Nutrition Group, which commenced its operations in 1971, has built up its current position as a global market leader by enlarging its operations organically and through M&A.
In 2007, private equity giant Blackstone signed a strategic alliance with ChemChina, the PRC's largest chemical company. As the capital component of the alliance, the US firm took 20% of BlueStar, investing $600 million. BlueStar bought the French group Adisseo in 2006, by acquiring 100% of Belgian holding company Drakkar Holdings S.A., which operated a subsidiary called Aventis Animal Nutrition (ANN), and changed the company's name to create the entity that sought to list in Hong Kong. Back in 2002, ANN sold 75% of its business to European private equity firm CVC Capital Partners and made the Adisseo Group companies subsidiaries of Drakkar Holdings.
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.








